Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Review ArticleClinical Review

Hepatitis C for Primary Care Physicians

Miranda M. Huffman and Anne L. Mounsey
The Journal of the American Board of Family Medicine March 2014, 27 (2) 284-291; DOI: https://doi.org/10.3122/jabfm.2014.02.130165
Miranda M. Huffman
From the Department of Community and Family Medicine, University of Missouri–Kansas City (MMH); and the Department of Family Medicine, University of North Carolina at Chapel Hill (ALM).
MD, MEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L. Mounsey
From the Department of Community and Family Medicine, University of Missouri–Kansas City (MMH); and the Department of Family Medicine, University of North Carolina at Chapel Hill (ALM).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Lauer GM,
    2. Walker BD
    . Hepatitis C virus infection. N Engl J Med 2001;345:41–52.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Ghany MG,
    2. Strader DB,
    3. Thomas DL,
    4. Seeff LB
    ; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335–74.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Armstrong GL,
    2. Wasley A,
    3. Simard EP,
    4. McQuillan GM,
    5. Kuhnert WL,
    6. Alter MJ
    . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–14.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Smith BD,
    2. Morgan RL,
    3. Beckett GA,
    4. et al
    . Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep 2012;61(RR-4):1–32.
    OpenUrlPubMed
  5. 5.↵
    Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47(RR-19):1–39.
    OpenUrlPubMed
  6. 6.↵
    1. Moyer VA
    ; U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159:349–57.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Chou R,
    2. Cottrell EB,
    3. Wasson N,
    4. et al
    . Screening for hepatitis C virus infection in adults. Comparative effectiveness reviews, no. 69 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; November 2012. Available from: http://www.ncbi.nlm.nih.gov/books/NBK115428/. Accessed January 22, 2014.
  8. 8.↵
    1. Kamal SM
    . Acute hepatitis C: a systematic review. Am J Gastroenterol 2008;103:1283–97.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Thomas D,
    2. Seeff L
    . Natural history of hepatitis C. Clin Liver Dis 2005;9:383–98.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Agnello V,
    2. De Rosa FG
    . Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004;40:341–52.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Zignego AL,
    2. Craxì A
    . Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 2008;12:611–36.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JB
    . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.
    1. Bush K,
    2. Kivlahan DR,
    3. McDonell MB,
    4. Fihn SD,
    5. Bradley KA
    . The AUDIT Alcohol Consumption Questionnaire (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 1998;158:1789–95.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Fontana RJ,
    2. Lok AS
    . Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):S57–64.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Backus LI,
    2. Boothroyd DB,
    3. Phillips BR,
    4. Belperio P,
    5. Halloran J,
    6. Mole LA
    . A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol 2011;9:509–16.e1.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Ghany MG,
    2. Nelson DR,
    3. Strader DB,
    4. Thomas DL,
    5. Seeff LB
    . An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:1433–44.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Liang TJ,
    2. Ghany MG
    . Current and future therapies for hepatitis C virus infection. N Engl J Med 2013;368:1907–17.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Lee LY,
    2. Tong CY,
    3. Wong T,
    4. Wilkinson M
    . New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract 2012;66:342–55.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Arora S,
    2. Thornton K,
    3. Murata G,
    4. et al
    . Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011;364:2199–207.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Khatri K,
    2. Haddad M,
    3. Anderson D
    . Project ECHO: replicating a novel model to enhance access to hepatitis C care in a community health center. J Health Care Poor Underserved 2013;24:850–8.
    OpenUrlPubMed
  21. 21.↵
    1. Shim M,
    2. Khaykis I,
    3. Park J,
    4. Bini EJ
    . Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 2005;42:688–95.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Tsai JF,
    2. Jeng JE,
    3. Ho MS,
    4. Chang WY,
    5. Lin ZY,
    6. Tsai JH
    . Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 1996;24:271–6.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–9.
    OpenUrlPubMed
  24. 24.↵
    1. Wiley TE,
    2. McCarthy M,
    3. Breidi L,
    4. McCarthy M,
    5. Layden TJ
    . Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998;28:805–9.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Corrao G,
    2. Aricò S
    . Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914–9.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Westin J,
    2. Lagging LM,
    3. Spak F,
    4. et al
    . Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002;9:235–41.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ortiz V,
    2. Berenguer M,
    3. Rayon JM,
    4. Carrasco D,
    5. Berenguer J
    . Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol 2002;9:2408–14.
    OpenUrl
  28. 28.↵
    1. Terrault NA,
    2. Dodge JL,
    3. Murphy EL,
    4. et al
    . Sexual transmission of HCV among monogamous heterosexual couples: the HCV Partners Study. Hepatology 2013;57:881–9.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Tohme RA,
    2. Holmberg SD
    . Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 2010;52:1497–505.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Onofrei MD,
    2. Butler KL,
    3. Fuke DC,
    4. Miller HB
    . Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008;28:522–9.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Bader T,
    2. Fazili J,
    3. Madhoun M,
    4. et al
    . Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 2008;103:1383–9.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Rao GA,
    2. Pandya PK
    . Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology 2011;140:144–52.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Tzefos M,
    2. Olin JL
    . 3-Hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. J Clin Lipidol 2011;5:450–9.
    OpenUrlPubMed
  34. 34.↵
    1. Calderon RM,
    2. Cubeddu LX,
    3. Goldberg RB,
    4. Schiff ER
    . Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc 2010;85:349–56.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Benson GD,
    2. Koff RS,
    3. Tolman KG
    . The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005;12:133–41.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Mehta G,
    2. Rothstein KD
    . Health maintenance issues in cirrhosis. Med Clin North Am 2009;93:901–15, viii–ix.
    OpenUrlPubMed
  37. 37.↵
    1. Castro-Fernández M,
    2. Sánchez-Muñoz D,
    3. Galán-Jurado MV,
    4. et al
    . Influence of nonsteroidal antiinflammatory drugs in gastrointestinal bleeding due to gastroduodenal ulcers or erosions in patients with liver cirrhosis. Gastroenterol Hepatol 2006;29:11–4.
    OpenUrlPubMed
  38. 38.↵
    1. Laffi G,
    2. La Villa G,
    3. Pinzani M,
    4. Marra F,
    5. Gentilini P
    . Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol 1997;17:530–48.
    OpenUrlPubMed
  39. 39.↵
    1. Hirschfield GM,
    2. Kumagi T,
    3. Heathcote EJ
    . Preventative hepatology: minimising symptoms and optimising care. Liver Int 2008;28:922–34.
    OpenUrlPubMed
  40. 40.↵
    1. Asnis GM,
    2. De La Garza R 2nd.
    . Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006;40:322–35.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Morasco BJ,
    2. Rifai MA,
    3. Loftis JM,
    4. et al
    . A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord 2007;103:83–90.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Bruix J,
    2. Sherman M
    . Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 27 (2)
The Journal of the American Board of Family Medicine
Vol. 27, Issue 2
March-April 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hepatitis C for Primary Care Physicians
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Hepatitis C for Primary Care Physicians
Miranda M. Huffman, Anne L. Mounsey
The Journal of the American Board of Family Medicine Mar 2014, 27 (2) 284-291; DOI: 10.3122/jabfm.2014.02.130165

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hepatitis C for Primary Care Physicians
Miranda M. Huffman, Anne L. Mounsey
The Journal of the American Board of Family Medicine Mar 2014, 27 (2) 284-291; DOI: 10.3122/jabfm.2014.02.130165
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Screening for Hepatitis C
    • Clinical Presentation
    • Diagnosis
    • Treatment
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Moral Distress with Obstacles to Hepatitis C Treatment: A Council of Academic Family Medicine Educational Research Alliance (CERA) Study of Family Medicine Program Directors
  • Correction to "Hepatitis C for Primary Care Physicians"
  • Investigating Patient-Centered Care
  • Google Scholar

More in this TOC Section

  • Interpretating Normal Values and Reference Ranges for Laboratory Tests
  • Non-Surgical Management of Urinary Incontinence
  • Screening and Diagnosis of Type 2 Diabetes in Sickle Cell Disease
Show more Clinical Review

Similar Articles

Keywords

  • Gastrointestinal Disorders
  • Hepatitis C

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire